• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精(IVF)中对控制性卵巢过度刺激(COH)“反应不良者”的干预措施。

Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF).

作者信息

Pandian Zabeena, McTavish Alison R, Aucott Lorna, Hamilton Mark Pr, Bhattacharya Siladitya

机构信息

Obstetrics & Gynaecology, Aberdeen Maternity Hospital, Foresterhill, Aberdeen, UK, AB25 2ZD.

出版信息

Cochrane Database Syst Rev. 2010 Jan 20(1):CD004379. doi: 10.1002/14651858.CD004379.pub3.

DOI:10.1002/14651858.CD004379.pub3
PMID:20091563
Abstract

BACKGROUND

The success of in-vitro fertilisation (IVF) depends on adequate follicle recruitment by using controlled ovarian stimulation with gonadotrophins. Failure to recruit adequate follicles is called 'poor response'. Various treatment protocols have been proposed that are targeted at this cohort of women, aiming to increase their ovarian response.

OBJECTIVES

To compare the effectiveness of different treatment interventions in women who have poor response to controlled ovarian hyperstimulation (are poor responders) in the context of IVF.

SEARCH STRATEGY

We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (MDSG) (5/1/2009), the Cochrane Central Register of Controlled trials (CENTRAL) (4th Quarter 2008), MEDLINE (1950 to November week 3 2008), EMBASE (1980 to 2008 week 52) and The National Research Register (NRR). The citation lists of relevant publications, review articles, abstracts of scientific meetings and included studies were also searched. The authors were contacted to clarify data that were unclear from the trial reports.

SELECTION CRITERIA

Only randomised controlled trials (RCTs) comparing one type of intervention versus another for controlled ovarian stimulation of poor responders to a previous IVF treatment, using a standard long protocol were included.

DATA COLLECTION AND ANALYSIS

Two reviewers independently scanned the abstracts, identified relevant papers, assessed trial quality and extracted relevant data for inclusion. Validity was assessed in terms of method of randomisation, completeness of treatment cycle and co-intervention. Where possible, data were pooled for analysis.

MAIN RESULTS

The new search identified fifteen trials. Three trials were eligible for inclusion. Ten trials involving eight different comparison groups have been included. Only one trial reported live birth rates.The number of oocytes retrieved were significantly less in the conventional GnRHa long protocol compared to stop protocol and GnRH antagonist protocol.Total dose of gonadotrophins used was significantly higher in the GnRHa long protocol group compared to the Stop protocol and GnRH antagonist groups.Cancellation rates were significantly higher in the GnRHa flare up group compared to the GnRHa long protocol group.None of the studies reported a difference in the miscarriage and ectopic pregnancy rates.

AUTHORS' CONCLUSIONS: There is insufficient evidence to support the routine use of any particular intervention either for pituitary down regulation, ovarian stimulation or adjuvant therapy in the management of poor responders to controlled ovarian stimulation in IVF. More robust data from good quality RCTs with relevant outcomes are needed.

摘要

背景

体外受精(IVF)的成功取决于使用促性腺激素进行控制性卵巢刺激以充分募集卵泡。未能充分募集卵泡被称为“反应不良”。已经提出了各种针对这一群体女性的治疗方案,旨在提高她们的卵巢反应。

目的

比较不同治疗干预措施对体外受精中控制性卵巢过度刺激反应不良(反应不佳者)的有效性。

检索策略

我们检索了Cochrane月经紊乱与不育症小组专门的对照试验注册库(MDSG)(2009年1月5日)、Cochrane对照试验中心注册库(CENTRAL)(2008年第4季度)、MEDLINE(1950年至2008年11月第3周)、EMBASE(1980年至2008年第52周)以及国家研究注册库(NRR)。还检索了相关出版物的引用列表、综述文章、科学会议摘要以及纳入研究。与作者联系以澄清试验报告中不明确的数据。

选择标准

仅纳入使用标准长方案对既往体外受精治疗反应不佳者进行控制性卵巢刺激时比较一种干预措施与另一种干预措施的随机对照试验(RCT)。

数据收集与分析

两名评审员独立浏览摘要、识别相关论文、评估试验质量并提取纳入的相关数据。根据随机化方法、治疗周期的完整性和共同干预评估有效性。尽可能合并数据进行分析。

主要结果

新的检索识别出15项试验。3项试验符合纳入标准。已纳入涉及8个不同比较组的10项试验。只有1项试验报告了活产率。与停止方案和GnRH拮抗剂方案相比,传统GnRHa长方案中获取的卵母细胞数量显著更少。与停止方案和GnRH拮抗剂组相比,GnRHa长方案组使用的促性腺激素总剂量显著更高。与GnRHa长方案组相比,GnRHa激发组的取消率显著更高。没有研究报告流产率和异位妊娠率存在差异。

作者结论

没有足够的证据支持在体外受精中对控制性卵巢刺激反应不佳者的管理中常规使用任何特定的干预措施来进行垂体降调节、卵巢刺激或辅助治疗。需要来自高质量RCT且有相关结局的更有力数据。

相似文献

1
Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF).体外受精(IVF)中对控制性卵巢过度刺激(COH)“反应不良者”的干预措施。
Cochrane Database Syst Rev. 2010 Jan 20(1):CD004379. doi: 10.1002/14651858.CD004379.pub3.
2
Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF).体外受精(IVF)中对控制性卵巢过度刺激(COH)“反应不良者”的干预措施。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD004379. doi: 10.1002/14651858.CD004379.pub2.
3
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
4
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5.
5
Growth hormone for in vitro fertilisation (IVF).促性腺激素在体外受精(IVF)中的应用。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD000099. doi: 10.1002/14651858.CD000099.pub4.
6
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.用于辅助生殖技术的促性腺激素释放激素拮抗剂
Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD001750. doi: 10.1002/14651858.CD001750.pub4.
7
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
8
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2011 Aug 10(8):CD006919. doi: 10.1002/14651858.CD006919.pub3.
9
WITHDRAWN: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.撤回:在辅助生殖周期中,人绝经期促性腺激素与重组卵泡刺激素用于卵巢刺激的比较。
Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003973. doi: 10.1002/14651858.CD003973.pub2.
10
In vitro fertilisation for unexplained subfertility.不明原因的亚生育力的体外受精。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003357. doi: 10.1002/14651858.CD003357.pub2.

引用本文的文献

1
Autologous platelet-rich plasma for assisted reproduction.自体富血小板血浆在辅助生殖中的应用。
Cochrane Database Syst Rev. 2024 Apr 29;4(4):CD013875. doi: 10.1002/14651858.CD013875.pub2.
2
Dehydroepiandrosterone modulates the PTEN/PI3K/AKT signaling pathway to alleviate 4-vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats.脱氢表雄酮通过调节 PTEN/PI3K/AKT 信号通路缓解 4-乙烯基环已烯二氧乙烷诱导的大鼠卵巢早衰。
Exp Anim. 2024 Jul 9;73(3):319-335. doi: 10.1538/expanim.23-0179. Epub 2024 Mar 16.
3
Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.
临床证据表明,生长激素可用于接受 IVF 治疗的卵巢储备功能减退的不孕女性:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Nov 7;14:1215755. doi: 10.3389/fendo.2023.1215755. eCollection 2023.
4
Gene expression and demographic analyses in women with the poor ovarian response: a computational approach.卵巢低反应女性的基因表达和人口统计学分析:一种计算方法。
J Assist Reprod Genet. 2023 Nov;40(11):2627-2638. doi: 10.1007/s10815-023-02919-4. Epub 2023 Aug 29.
5
Fertility With Early Reduction of Ovarian Reserve.卵巢储备功能早期下降时的生育力
Cureus. 2022 Oct 15;14(10):e30326. doi: 10.7759/cureus.30326. eCollection 2022 Oct.
6
Comparative analyses in transcriptome of human granulosa cells and follicular fluid micro-environment between poor ovarian responders with conventional controlled ovarian or mild ovarian stimulations.常规控制性卵巢刺激或轻度卵巢刺激的卵巢低反应者中人类颗粒细胞转录组与卵泡液微环境的比较分析。
Reprod Biol Endocrinol. 2022 Mar 21;20(1):54. doi: 10.1186/s12958-022-00926-1.
7
Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients.在 POSEIDON 4 组患者中,枸橼酸氯米酚与来曲唑联合应用与常规控制性卵巢刺激的比较。
Front Endocrinol (Lausanne). 2022 Jan 14;12:780392. doi: 10.3389/fendo.2021.780392. eCollection 2021.
8
VEGF Concentration in a Preovulatory Leading Follicle Relates to Ovarian Reserve and Oocyte Maturation during Ovarian Stimulation with GnRH Antagonist Protocol in In Vitro Fertilization Cycle.在体外受精周期中采用GnRH拮抗剂方案进行卵巢刺激时,排卵前优势卵泡中的VEGF浓度与卵巢储备和卵母细胞成熟有关。
J Clin Med. 2021 Oct 28;10(21):5032. doi: 10.3390/jcm10215032.
9
The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient.卵巢低反应相关风险因素的探索:生长分化因子 8 在预测 IVF-ET 患者卵巢反应中的潜在作用。
Front Endocrinol (Lausanne). 2021 Sep 24;12:708089. doi: 10.3389/fendo.2021.708089. eCollection 2021.
10
Cumulative live birth rates do not increase after 4 complete cycles in women with poor ovarian response: a retrospective study of 1,825 patients.卵巢反应不良女性在4个完整周期后累积活产率并未增加:一项对1825例患者的回顾性研究。
F S Rep. 2021 Feb 2;2(2):201-208. doi: 10.1016/j.xfre.2021.01.004. eCollection 2021 Jun.